Skip to main content
NAC Logo NAC Logo (English) NAC Logo (Français)
National Advisory Committee on Blood and Blood Products (NAC)
  • EN
  • FR
  • Blood Shortage
  • Endorsements
  • Guidelines & Recommendations
    • Blood Component Transfusion Recommendations
    • Plasma Protein and Related Products Recommendations
    • Special Testing / Modification Recommendations
    • Adverse Event Recommendations
    • Infection Prevention and Control
  • Archived Documents
  • Links & Resources
  • Citations
NAC Logo NAC Logo (English) NAC Logo (Français)
National Advisory Committee on Blood and Blood Products (NAC)

Main navigation

  • Blood Shortage
  • Endorsements
  • Guidelines & Recommendations
    • Blood Component Transfusion Recommendations
    • Plasma Protein and Related Products Recommendations
    • Special Testing / Modification Recommendations
    • Adverse Event Recommendations
    • Infection Prevention and Control
  • Archived Documents
  • Links & Resources
  • Citations
  • EN
  • FR

Breadcrumb

  • Home
  • Guidelines & Recomme...
  • Current: Special Testing / Modification Recommendations

Special Testing / Modification Recommendations

This section is dedicated to recommendations on special testing and/or modification of blood components and their utilization, including the use of irradiated components and CMV seronegative components. Special testing of donors / recipients, such as RhD genotyping of prenatal patients, is also included.
NAC Statement on RBC Genotyping
Download PDF (553.17 KB)
Copy citation
RHD Genotyping in Prenatal Patients
Download PDF (223.15 KB)
Transfusion and Cytomegalovirus in the Canadian Blood System Supported by Canadian Blood Services*
Download PDF (486.76 KB)
Copy citation
Supplement to the NAC-CCNMT Recommendations for Use of Irradiated Blood Components in Canada
Download PDF (503.35 KB)
Recommendations for Use of Irradiated Blood Components in Canada
Download PDF (1.43 MB)
Copy citation
NAC Logo NAC Logo (English) NAC Logo (Français)
National Advisory Committee on Blood and Blood Products (NAC)

NAC

  • Blood Shortage
  • Endorsements
  • Guidelines & Recommendations
  • Archived Documents
  • Links & Resources
  • Citations

Recently updated resources

  • Recommendations for the Notification of Recipients of a Blood Component Recall
  • Overview of Adverse Transfusion Reaction Reporting for Hospitals in Canada: a NAC and Québec Hemovigilance System Collaborative Initiative
  • NAC Statement on RBC Genotyping
  • Recommendations for Use of Prothrombin Complex Concentrates in Canada
  • Whole Blood, Leukocytes Reduced Recommendations

Contact

NAC Chair

Andrew Shih

NAC Project Coordinator

Kendra Stuart

info@nac.blood.ca

© Copyright 2025. National Advisory Committee on Blood and Blood Products. All rights reserved. Disclaimer & Privacy Info